Når ny information er modtaget, der kan have en indflydelse på den gældende Safety Specification, pharmacovigilance- plan eller aktiviteter for risikominimering
When new information is received that may impact on the current Safety Specification, Pharmacovigilance Plan or risk minimisation activities.